Atika Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-22,000
| Closed | -$2.24M | – | 101 |
|
|
2023
Q2 | $2.24M | Buy |
+22,000
| New | +$2.24M | 0.22% | 67 |
|
|
2021
Q3 | – | Sell |
-48,000
| Closed | -$6.79M | – | 129 |
|
|
2021
Q2 | $6.79M | Buy |
+48,000
| New | +$6.79M | 0.54% | 65 |
|
|
2020
Q3 | – | Sell |
-68,500
| Closed | -$10.7M | – | 113 |
|
|
2020
Q2 | $10.7M | Sell |
68,500
-13,500
| -16% | -$2.11M | 1.38% | 20 |
|
|
2020
Q1 | $11.8M | Buy |
82,000
+19,500
| +31% | +$2.81M | 2.27% | 10 |
|
|
2019
Q4 | $12.8M | Buy |
+62,500
| New | +$12.8M | 2.47% | 6 |
|